In the current study, we investigated the role of SLAMF5 in the development of EAE by examining its expression on myeloid cell populations in both the brain and peripheral tissues of EAE-induced mice, as well as in the peripheral blood of MS patients and in induced pluripotent stem cell (iPSC)-derived microglia. The gene discussed is CD84; the disease is myeloid sarcoma.